Growth patterns among HIV-exposed infants receiving nevirapine prophylaxis in Pune, India

Growth patterns among HIV-exposed infants receiving nevirapine prophylaxis in Pune, India

<p>Abstract</p> <p>Background</p> <p>India has among the highest rates of infant malnutrition. Few studies investigating the growth patterns of HIV-exposed infants in India or the impact of timing of HIV infection on growth in settings such as India exist.</p> <...

Full description

Bibliographic Details
Main Authors:	Ram Malathi, Gupte Nikhil, Nayak Uma, Kinikar Aarti A, Khandave Mangesh, Shankar Anita V, Sastry Jayagowri, Bollinger Robert C, Gupta Amita
Format:	Article
Language:	English
Published:	BMC 2012-10-01
Series:	BMC Infectious Diseases
Subjects:	HIV-exposed infants Growth patterns India Extended use of nevirapine Risk factors Timing of HIV Infection
Online Access:	http://www.biomedcentral.com/1471-2334/12/282

Similar Items

Efficacy of Mobile phone use on adherence to Nevirapine prophylaxis and retention in care among the HIV-exposed infants in prevention of mother to child transmission of HIV: a randomized controlled trial
by: Lilian M. N. Kebaya, et al.
Published: (2021-04-01)

Investigating the continuous synthesis of a nicotinonitrile precursor to nevirapine
by: Ashley R. Longstreet, et al.
Published: (2013-11-01)

Nevirapine-induced side effects in pregnant women: experience of a brazilian university hospital
by: William Kondo, et al.

Perbandingan Penggunaan Efavirenz dan Nevirapine Terhadap Kolesterol LDL Pasien HIV/AIDS
by: Anggriani Yusi, et al.
Published: (2019-08-01)

Detection of HIV drug resistance mutations in pregnant women receiving single dose Nevirapine in south India
by: Mini S Jacob, et al.
Published: (2011-01-01)

Nevirapine in HIV maintenance therapy – can “old drugs” survive in current HIV management?
by: Julia Notter, et al.
Published: (2019-04-01)

Rate of viral load change and adherence of HIV adult patients treated with Efavirenz or Nevirapine antiretroviral regimens at 24 and 48 weeks in Yaoundé, Cameroon: a longitudinal cohort study
by: Bih Hycenta Chendi, et al.
Published: (2019-02-01)

Combined antiretroviral therapy with nevirapine of HIV-infected adults
by: A V Kravchenko
Published: (2004-11-01)

Oxidation of 2-Hydroxynevirapine, a Phenolic Metabolite of the Anti-HIV Drug Nevirapine: Evidence for an Unusual Pyridine Ring Contraction
by: Frederick A. Beland, et al.
Published: (2012-03-01)

Similar HIV protection from four weeks of zidovudine versus nevirapine prophylaxis among formula-fed infants in Botswana
by: Kathleen M. Powis, et al.
Published: (2018-03-01)

Nevirapine-induced Stevens-Johnson syndrome in children living with HIV in South Africa
by: Jacques D. du Toit, et al.
Published: (2021-02-01)

Longitudinal adherence to maternal antiretroviral therapy and infant Nevirapine prophylaxis from 6 weeks to 18 months postpartum amongst a cohort of mothers and infants in South Africa
by: Anna Larsen, et al.
Published: (2019-09-01)

Should nevirapine be used to prevent mother-to-child transmission of HIV among women of unknown serostatus?
by: Tin Tin Sint, et al.

High Rates of All-cause and Gastroenteritis-related Hospitalization Morbidity and Mortality among HIV-exposed Indian Infants
by: Tripathy Srikanth, et al.
Published: (2011-07-01)

Solid State Characterization and Dissolution Enhancement of Nevirapine Cocrystals
by: Prabhakar Panzade, et al.
Published: (2021-09-01)

Me-Better Drug Design Based on Nevirapine and Mechanism of Molecular Interactions with Y188C Mutant HIV-1 Reverse Transcriptase
by: Yan Wang, et al.
Published: (2022-10-01)

Efavirenz challenge in patients with nevirapine induced Stevens-Johnson Syndrome
by: Thandekile C. Manzini, et al.
Published: (2016-12-01)

Efficacy and safety of switching from nevirapine immediate-release twice daily to nevirapine extended-release once daily in virologically suppressed HIV-infected patients: a retrospective cohort study in Taiwan
by: Chun-Yuan Lee, et al.
Published: (2017-04-01)

Possible hepatotoxic consequence of nevirapine use in juvenile albino rats
by: Elias Adikwu, et al.
Published: (2017-08-01)

Mother-to-Child Transmission of HIV and Associated Factors Among Exposed Infants in Pastoralist Health Facilities, South Omo Zone, Ethiopia, 2020 – A Retrospective Cross-Sectional Study
by: Tadewos K, et al.
Published: (2021-12-01)

Green HPLC quantification method of lamivudine, zidovudine and nevirapine with identification of related substances in tablets
by: Ludivine Vieira-Sellaï, et al.
Published: (2022-07-01)

Mother-to-Child Transmission of HIV and Its Predictors Among HIV-Exposed Infants at an Outpatient Clinic for HIV/AIDS in Vietnam
by: Nguyen RN, et al.
Published: (2020-07-01)

Clinical and genetic factors associated with increased risk of severe liver toxicity in a monocentric cohort of HIV positive patients receiving nevirapine-based antiretroviral therapy
by: Andrea Giacomelli, et al.
Published: (2018-11-01)

Long-term efficacy and safety of nevirapine-containing regimens in virologically suppressed patients: a 17-year follow up
by: Juan Tiraboschi, et al.
Published: (2019-11-01)

Dipyridodiazepinone derivatives; synthesis and anti HIV-1 activity
by: Nisachon Khunnawutmanotham, et al.
Published: (2009-07-01)

Cost-effectiveness of childbirth strategies for prevention of mother-to-child transmission of HIV among mothers receiving nevirapine in India
by: Mukherjee Kanchan
Published: (2010-01-01)

AMELIORATIVE EFFECTS OF VITAMINS C AND E ON TENOFOVIR/NEVIRAPINE-INDUCED HEPATORENAL OXIDATIVE STRESS IN ALBINO RATS
by: Elias Adikwu, et al.
Published: (2016-10-01)

High risk for occupational exposure to HIV and utilization of post-exposure prophylaxis in a teaching hospital in Pune, India
by: Gupte Nikhil, et al.
Published: (2008-10-01)

The effects of exposure to HIV in neonates at a referral hospital in South Africa
by: Helena Mellqvist, et al.
Published: (2021-11-01)

Clinical and immunological outcomes of HIV-exposed uninfected and HIV-unexposed uninfected children in the first 24 months of life in Western Kenya
by: Jessica E. Ray, et al.
Published: (2024-02-01)

Studies on some neuropharmacological properties of Nevirapine in mice
by: Peter Uchogu Ahmadu, et al.
Published: (2022-06-01)

Nevirapine- versus Efavirenz-based antiretroviral therapy regimens in antiretroviral-naive patients with HIV and Tuberculosis infections in India: a multi-centre study
by: Sanjeev Sinha, et al.
Published: (2017-12-01)

Feeding practices and nutritional status of HIV-exposed and HIV-unexposed infants in the Western Cape
by: Magdel E. Rossouw, et al.
Published: (2016-05-01)

Prevalence of tuberculosis among perinatally exposed to HIV and HIV-infected children and predictors of its development
by: V. A. Kukarkina, et al.
Published: (2021-07-01)

Antiretroviral therapy during pregnancy and early neonatal life: consequences for HIV-exposed, uninfected children
by: Patrícia El Beitune, et al.

Mother-to-child transmission of HIV and its predictors among HIV-exposed infants at Bamenda Regional Hospital, Cameroon
by: Victor N. Fondoh, et al.
Published: (2017-12-01)

Retention of HIV exposed infants in care at Arua regional referral hospital, Uganda: a retrospective cohort study
by: Pontius Apangu, et al.
Published: (2019-04-01)

Predictors of mortality among HIV exposed infants at University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia
by: Chalachew Adugna Wubneh, et al.
Published: (2019-11-01)

Feeding Experiences of HIV-Exposed Preterm Infants Among Mothers Living with HIV in Addis Ababa, Ethiopia: A Qualitative Study
by: Getachew B, et al.
Published: (2021-11-01)

Increased platelets count in HIV-1 uninfected infants born from HIV-1 infected mothers
by: Anicet Christel Maloupazoa Siawaya, et al.
Published: (2019-09-01)